Desmopressin Effective for Nocturia in Women
Two studies show significant reduction in number of nocturnal voids for women.
Diagnosis & Disease Information
Nocturia May Predict Heart Problems
The prevalence and severity of nocturia, or awakening at least once at night to urinate, tends to increase with age.
Nocturia May Raise Death Risk in Older Men
Moderate nocturia may increase the risk of death among men aged 60 years and older, according to study. Among younger men, it may increase the likelihood of developing coronary heart disease later in life.
Insufficient Evidence for Routine Bladder Cancer Screening
In an update to its 2004 guidance on screening for bladder cancer, the United States Preventive Services Task Force (USPSTF) has changed its recommendation from a D (lack of evidence) to an I (insufficient evidence) statement, finding inadequate data to support disease screening for asymptomatic adults or for adults with mild lower urinary tract symptoms such as urinary frequency, hesitancy, urgency, dysuria, or nocturia.
Childhood Bedwetting Predicts Adult Enuresis
GLASGOW—Bedwetting in childhood is a strong indicator of persisting enuresis in adulthood, researchers concluded in a report presented here at the International Continence Society annual meeting.
Nocturia Is the Most Bothersome OAB Symptom in POTS Patients
WASHINGTON, D.C.—Nocturia is the most common overactive bladder (OAB) symptom affecting health-related quality of life (HRQL) in patients with postural tachycardia syndrome (POTS), investigators reported at the American Urological Association 2011 annual meeting.
Nocturia May Increase Mortality Risk
SAN FRANCISCO—Nocturia, defined as two or more urinations per night, is associated with an increased risk of death, even after adjusting for comorbidities known to increase mortality, according to two new studies presented at the American Urological Association annual meeting.
Research on a New Drug For Nocturia Advances
Vantia Therapeutics, a British pharmaceutical company, has begun a Phase 2b trial of its lead development compound VA106483 for nocturia, according to a company statement.
Novel ESRD Risk Factors Identified
Researchers have identified four new independent risk factors for the development of end-stage renal disease (ESRD). These are higher serum uric acid levels, lower hemoglobin levels, family history of kidney disease, and self-reported history of nocturia.
Celecoxib Works for BPH with Nocturia
Celecoxib is effective for treating BPH patients with refractory nocturia, researchers in Iran reported in Urology (2008; online ahead of print).
- Loading...
Loading...
Next post in Benign Prostatic Hyperplasia (BPH)
Loading... 
Loading...